3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial
- Submitting institution
-
University of Glasgow
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 1-01213
- Type
- D - Journal article
- DOI
-
10.1016/S1470-2045(18)30093-7
- Title of journal
- Lancet Oncology
- Article number
- -
- First page
- 562
- Volume
- 19
- Issue
- 4
- ISSN
- 1470-2045
- Open access status
- Compliant
- Month of publication
- April
- Year of publication
- 2018
- URL
-
http://eprints.gla.ac.uk/156527/
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- Yes
- Number of additional authors
-
35
- Research group(s)
-
-
- Citation count
- 67
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- The author made a substantial contribution to the conception and design of the study, the analysis and interpretation of study data AND the author helped to draft the output and critiqued the output for important intellectual content.
- Non-English
- No
- English abstract
- -
